Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.56 |
| ▸ | NPC1 | O15118 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 11/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 9/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 9/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 9/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ACACB | O00763 | 1/20 | 0.43 |
| ▸ | ACACA | Q13085 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15382000 | 0.94 | RARB (0.52) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL991056 | 0.94 | ACACB (0.50) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL8956327 | 0.92 | NPC1 (0.49) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL991686 | 0.87 | TP53 (0.47) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL13578477 | 0.86 | TUBB4A (0.48) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL8605824 | 0.86 | NR1I2 (0.44) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL14257518 | 0.83 | RAB9A (0.66) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL10156182 | 0.82 | LMNA (0.57) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL13873049 | 0.81 | CYP2D6 (0.38) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL13873053 | 0.81 | CYP2D6 (0.38) | RAB9ANPC1SMN1; SMN2HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100726-A1 | DECORATIVE FILM, ELECTRONIC MEMBER, AND TOUCH PAD | JSR株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20260085194-A1 | OPTICAL PRODUCT | TOKYO OHKA KOGYO CO LTD (JP) | 2026-03-26 | — | — | US | disclosed |
| US-12523930-B2 | Nanoimprint composition and pattern forming method | TOKYO OHKA KOGYO CO., LTD. (JP) | 2026-01-13 | — | — | US | disclosed |
| US-20250333548-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO LTD (JP) | 2025-10-30 | — | — | US | disclosed |
| US-20250321481-A1 | PHOTOSENSITIVE RESIN COMPOSITION | TOKYO OHKA KOGYO CO LTD (JP) | 2025-10-16 | — | — | US | disclosed |
| US-12422749-B2 | Photosensitive ink composition, cured product, display panel, and method for producing cured product | TOKYO OHKA KOGYO CO., LTD. (JP) | 2025-09-23 | — | — | US | disclosed |
| US-20250289926-A1 | CURABLE COMPOSITION FOR INSULATING FILM FORMATION, INSULATING FILM FORMATION METHOD, AND TERMINALLY MALEIMIDE-MODIFIED POLYPHENYLENE ETHER RESIN | TOKYO OHKA KOGYO CO LTD (JP) | 2025-09-18 | — | — | US | disclosed |
| US-20250282900-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2025-09-11 | — | — | US | disclosed |
| US-12379664-B2 | Photosensitive ink composition, cured product, display panel, and method for producing cured product | TOKYO OHKA KOGYO CO., LTD. (JP) | 2025-08-05 | — | — | US | disclosed |
| US-20250189891-A1 | POLYIMIDE RESIN PRECURSOR | TOKYO OHKA KOGYO CO., LTD. (JP) | 2025-06-12 | — | — | US | disclosed |
| US-20050130055-A1 | Method and removing resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2005-06-16 | — | — | US | disclosed |
| EP-1338436-A2 | Aluminum support for lithographic printing plate, method of preparing the same and presensitized plate using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2003-08-27 | — | — | EP | disclosed |
| EP-0671661-B1 | Photosensitive lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 1999-08-25 | — | — | EP | disclosed |
| EP-0633500-B1 | Photosensitive composition and process for image formation | FUJI PHOTO FILM CO LTD (JP) | 1998-11-11 | — | — | EP | disclosed |
| EP-0684521-B1 | Positive working photosensitive compositions | FUJI PHOTO FILM CO LTD (JP) | 1998-01-14 | — | — | EP | disclosed |
| EP-0684521-A1 | Positive working photosensitive compositions | FUJI PHOTO FILM CO., LTD. (JP) | 1995-11-29 | — | — | EP | disclosed |
| EP-0671661-A2 | Photosensitive lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
| EP-0633500-A1 | Photosensitive composition and process for image formation | FUJI PHOTO FILM CO., LTD. (JP) | 1995-01-11 | — | — | EP | disclosed |
| US-5180653-A | Triazine Compound, Cresol Novolak, Alkoxymethylated Melamine | TOKYO OHKA KOGYO CO., LTD. (JP) | 1993-01-19 | — | — | US | disclosed |
| US-5057397-A | Fine patterning of semiconductor | TOKYO OHKA KOGYO CO., LTD. (JP) | 1991-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085194-A1 | OPTICAL PRODUCT | PFN1, CFL1, C9 | RAB9A 2794/4885NPC1 2724/4885SMN1; SMN2 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.